Currency In USD
| Previous Close | 4.31 |
| Open | 4.14 |
| Day High | 4.48 |
| Day Low | 4.12 |
| 52-Week High | 7.2 |
| 52-Week Low | 3.1 |
| Volume | 34,466 |
| Average Volume | 27,649 |
| Market Cap | 7.98M |
| PE | -0.25 |
| EPS | -16.33 |
| Moving Average 50 Days | 3.73 |
| Moving Average 200 Days | 4.5 |
| Change | -0.17 |
CSE Bulletin: Consolidation - Bolt Metals Corp. (BOLT)
Newsfile
Oct 20, 2025 4:58 PM GMT
Toronto, Ontario--(Newsfile Corp. - Le 20 octobre/October 2025) - Bolt Metals Corp. has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidated common share for every twenty five (25) pre-
Bolt Biotherapeutics Provides Update on BDC-4182 and Extends Cash Runway into 2027
GlobeNewswire Inc.
Oct 01, 2025 8:05 PM GMT
Initial clinical data for BDC-4182 Phase 1 dose escalation study now expected in 3Q 2026Company is implementing a 50% workforce reduction to extend cash runway into 2027 REDWOOD CITY, Calif., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics (
Bolt Biotherapeutics to Host KOL Conference Call and Webcast to Discuss BDC-3042 Phase 1 Results and Corporate Updates
GlobeNewswire Inc.
May 08, 2025 12:00 PM GMT
Conference call and webcast on Monday, May 12, 2025, at 2:30 p.m. PT / 5:30 p.m. ET REDWOOD CITY, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics (Nasdaq: BOLT), a biopharmaceutical company developing novel immunotherapies for the tre